Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-033607
Filing Date
2013-06-07
Accepted
2013-06-07 17:08:30
Documents
1
Period of Report
2013-06-05

Document Format Files

Seq Description Document Type Size
1 E. WEBER ANNUAL GRANT rrd382414.html 4  
1 E. WEBER ANNUAL GRANT rrd382414.xml 4 4320
  Complete submission text file 0001181431-13-033607.txt   5716
Mailing Address C/O DOMAIN ASSOCIATES ONE PALO SQ PRINCETON NJ 08542
Business Address
WEBER ECKARD (Reporting) CIK: 0001279800 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33415 | Film No.: 13901410

Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Issuer) CIK: 0001382911 (see all company filings)

EIN.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations